Check out this week's QuadCast as we highlight PACIFIC-2 using concurrent durvalumab in NSCLC, predictive MRI features for prostate cancer outcomes, the benefit of radiation in H&N Merkel cell carcinoma, and more!
Check out this week's QuadCast as we highlight PACIFIC-2 using concurrent durvalumab in NSCLC, predictive MRI features for prostate cancer outcomes, the benefit of radiation in H&N Merkel cell carcinoma, and more!